Replimune Group
REPL
REPL
157 hedge funds and large institutions have $943M invested in Replimune Group in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+14
Holders Change %
+9.79%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
34
Increased
66
Reduced
32
Closed
19
Calls
$536K
Puts
$528K
Net Calls
+$8K
Net Calls Change
+$722K
Top Buyers
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$37.6M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$18.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.1M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$11.5M |
| 5 |
RI
RTW Investments
New York
|
+$11.3M |
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$19.3M |
| 2 |
FIS
FCPM III Services
Naarden,
Netherlands
|
-$10.8M |
| 3 |
Morgan Stanley
New York
|
-$7.78M |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$5.89M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.95M |
